Click a link below to view the mailing archive as if it had been sent to you.
| 2021-10-31 00:15 | | Why Pfizer Isn't the Big Winner With a Newly Approved Version of Chantix and more... |
| 2021-10-30 12:15 | | FDA clears Pfizer's Covid-19 vaccine for children ages 5-11 |
| 2021-10-29 12:15 | | Despite strong quarter, some wonder how long Gilead can rely on coronavirus drug and more... |
| 2021-10-29 00:15 | | Merck sees up to $7B in coming sales of coronavirus pill and more... |
| 2021-10-28 12:15 | | Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says and more... |
| 2021-10-28 00:15 | | FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases and more... |
| 2021-10-27 12:15 | | GE Healthcare supply chain woes: Like 'Whac-A-Mole,' to last into 2022 and more... |
| 2021-10-27 00:15 | | FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children and more... |
| 2021-10-26 12:15 | | Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm and more... |
| 2021-10-26 00:15 | | FDA Publishes De Novo Classification Final Rule with Few Changes from the Proposed Rule and more... |
| 2021-10-25 12:15 | | AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer and more... |
| 2021-10-25 00:15 | | Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout and more... |
| 2021-10-23 00:15 | | Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows and more... |
| 2021-10-22 12:15 | | Pfizer pitches its Covid-19 vaccine for younger children ahead of adcomm next week and more... |
| 2021-10-22 00:15 | | Medtronic's newest insulin pump improves blood sugar control in children with diabetes: study and more... |
| 2021-10-21 12:15 | | Pfizer, in a first, shows booster shot strengthens COVID-19 protection in large study and more... |
| 2021-10-21 00:15 | | FDA authorizes additional Moderna, J&J shots, broadening booster rollout and more... |
| 2021-10-20 12:15 | | Biogen CEO Says Alzheimer's Uptake 'Is Delayed,' But Shares Pop On Earnings Beat and more... |
| 2021-10-20 00:15 | | Pfizer-BioNTech’s vaccine is highly effective against hospitalization for those 12 to 18, a study shows. and more... |
| 2021-10-19 12:15 | | Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst and more... |
| 2021-10-19 00:15 | | Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat and more... |
| 2021-10-18 12:15 | | FDA OKs an inhaled version of smoking cessation drug Chantix — for a common eye disease and more... |
| 2021-10-18 00:15 | | Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS and more... |
| 2021-10-17 00:15 | | FDA adds Class I recall label to Abbott Alinity COVID tests after risk of false positives and more... |
| 2021-10-16 00:15 | | FDA Panel Unanimously Recommends J&J Booster Shot and more... |
| 2021-10-15 12:15 | | Illumina Makes First Imprint on GRAIL with New CEO and more... |
| 2021-10-15 00:15 | | FDA advisers unanimously back Moderna booster shot for many Americans and more... |
| 2021-10-14 12:15 | | Biden official warns Moderna to 'step up' on vaccine doses for the world and more... |
| 2021-10-14 00:15 | | Ardelyx axes 65% of workforce with no clarity from FDA on kidney drug's future and more... |
| 2021-10-13 12:15 | | GSK tangoes with private equity players to explore $54B sale of consumer unit instead of IPO — report and more... |
| 2021-10-13 00:15 | | bluebird bio provides update on 2seventy bio spin-off and more... |
| 2021-10-12 12:15 | | Pfizer-BioNTech Lead Globally with COVID-19 Vaccine and more... |
| 2021-10-12 00:15 | | CDC sets panel meetings for J&J, Moderna boosters, child vaccines and more... |
| 2021-10-11 12:15 | | Merck asks FDA to authorize promising anti-COVID pill and more... |
| 2021-10-11 00:15 | | Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late? and more... |
| 2021-10-10 00:15 | | Regeneron Could Have a Big Catalyst Coming in 2022 and more... |
| 2021-10-08 12:15 | | Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules and more... |
| 2021-10-08 00:15 | | CDC director defends decision to overrule expert panel on Covid booster shots for health and other frontline workers and more... |
| 2021-10-07 12:15 | | Bristol Myers Squibb's deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster and more... |
| 2021-10-07 00:15 | | Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT and more... |
| 2021-10-06 12:15 | | With D.C. drug pricing negotiations still up in the air, the 'endgame' could still 'have a bite,' analyst says and more... |
| 2021-10-06 00:15 | | Abbott CEO Robert Ford to Give CES 2022 Keynote and more... |
| 2021-10-05 12:15 | | Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines and more... |
| 2021-10-05 00:15 | | Elizabeth Holmes knew machines weren’t working, former Theranos lab director testifies and more... |
| 2021-10-04 12:15 | | J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race and more... |
| 2021-10-04 00:15 | | FDA to hold advisory meetings for Moderna & J&J boosters, pediatric COVID-19 vaccines and more... |
| 2021-10-01 12:15 | | Trouble builds for Merck's $11.5B Acceleron buy as activist investor behind Gilead's Immunomedics deal says too early, too cheap and more... |
| 2021-10-01 00:15 | | U.S. House panel approves fourth bill aimed at drug prices and more... |
